Tag: Life Sciences

Square
By Vistatec Posted on

The Ethics of AI in Regulated Life Sciences

In life sciences and other highly regulated industries, we must balance the desire for innovation and efficiency with our industry mandate to do no harm. We must be particularly thoughtful in implementing and using AI because mistakes in our industry can cause life-altering consequences. We cannot currently depend solely on AI vendors to determine what guardrails are necessary and desirable for our industry, which often has a higher standard of care than the tool vendors. … Continue readingThe Ethics of AI in Regulated Life Sciences

By Vistatec Posted on

Translating Medical Devices: A Rule-Driven Game

We are pleased to present an extract from a new article authored by Karen Tkaczyk Ph.D., Director of Sales at Vistatec, for this month’s European Medical Writers Association. This article titled “Translating medical devices: A rule-driven game” is available in its entirety on the European Medical Writers Association website, free of charge. The below extract provides a glimpse into the valuable insights provided in the full article, which we believe will be of great interest to our esteemed medical professional audience. … Continue readingTranslating Medical Devices: A Rule-Driven Game

By Vistatec Posted on

Inspiring Hope and the Impact of Diversity, Equity, and Innovation in Life Sciences: Eliana R. Burke, GreenLight Clinical – Life Sciences — In Focus Podcast Ep 2

In this Vistatec Life Sciences – In Focus Podcast episode, we hosted Eliana R. Burke, the Global Head of Client Engagement and Marketing at GreenLight Clinical. Eliana brought her professional prowess into the limelight. She shared her deeply personal and inspirational journey as a cancer survivor, melding professional dedication and personal resilience into a narrative that’s both empowering and enlightening. … Continue readingInspiring Hope and the Impact of Diversity, Equity, and Innovation in Life Sciences: Eliana R. Burke, GreenLight Clinical – Life Sciences — In Focus Podcast Ep 2

By Vistatec Posted on

Life Sciences — In Focus: Real-World Evidence: Global Regulatory Landscape and Innovation

Real-world evidence (RWE) has been a hot topic in recent years, not only in the research and life sciences industry but also in public health. Given the challenges surrounding its ethical use and regulation, the increasing importance of AI and the sheer volume of data available suggest that this is unlikely to change any time soon. Vistatec invited industry-leading experts to share their insights, thoughts, and predictions on the role of RWE going forward at our recent “Real-World Evidence: Global Regulatory Landscape and Innovation” event.
… Continue readingLife Sciences — In Focus: Real-World Evidence: Global Regulatory Landscape and Innovation

By Vistatec Posted on

Driving Diversity and Change in the Life Sciences Industry with Aman Khera: Life Sciences — In Focus Podcast Episode 1

In this new episode of the Life Sciences — In Focus podcast, hosted by Karen Tkaczyk, we welcomed a genuinely remarkable guest, Aman Khera, Vice President of Regulatory Science, Strategy, and Innovation at Worldwide Clinical Trials. With a career spanning nearly three decades, Khera is a force of innovation and a staunch advocate for diversity and patient inclusion in clinical research. Her journey from a curious student in the UK to a leading executive in the clinical research organization (CRO) space is a testament to her passion, resilience, and dedication to making healthcare better for all. … Continue readingDriving Diversity and Change in the Life Sciences Industry with Aman Khera: Life Sciences — In Focus Podcast Episode 1

By Vistatec Posted on

Transparency, Comprehension, and Compliance: Key Factors in Translating and Localizing Lay Summaries (LS)

Lay summaries (LS) “translate” complex medical terminology and concepts into language patients and consumers can understand – a task that must done carefully to avoid losing meaning or accuracy. Making these available in multiple languages is a highly complex, intricate process that requires the expertise of an experienced life sciences localization team to ensure successful communication and cultural appropriateness. … Continue readingTransparency, Comprehension, and Compliance: Key Factors in Translating and Localizing Lay Summaries (LS)

By Emily Carroll Posted on

Life Sciences Localization Strategy and Insights – Karen Tkaczyk – VistaTalks – Ep 136

Life Sciences expert Karen Tkaczyk joins VistaTalks host María Roa on this podcast episode. Karen is a distinguished figure in the translation and language services sector, particularly within the life sciences domain. Currently Director of Sales – Life Sciences at Vistatec, Karen possesses a rare blend of scientific expertise and linguistic prowess, making her contributions invaluable to companies aiming to globalize their operations. … Continue readingLife Sciences Localization Strategy and Insights – Karen Tkaczyk – VistaTalks – Ep 136

By Vistatec Posted on

Introducing the Life Sciences — In Focus Podcast: Expert Insights in Life Sciences

Welcome to the introductory episode of the Life Sciences — In-Focus podcast, brought to you by Vistatec. The podcast introduces a new avenue for exploring the dynamic and ever-evolving world of life sciences. Episode 0 expertly set the stage for what promises to be a series of insightful and engaging discussions. Read the recap here. … Continue readingIntroducing the Life Sciences — In Focus Podcast: Expert Insights in Life Sciences

By Vistatec Posted on

Language, Translation and Localization: Key Factors in Decentralized Clinical Trials (DCTs)

With improved guidance and the maturation of digital health technologies (DHTs), decentralized clinical trials (DCTs) are here to stay. This is excellent news in many ways: DCTs provide a path to addressing tough, longstanding challenges in clinical trials. Properly planned and executed, DCTs allow for accelerated cohort recruitment and clinical development timelines. Additional benefits include enhanced retention, better participant adherence, greater diversity, and more representative patient access, leading to a more robust evidence base. … Continue readingLanguage, Translation and Localization: Key Factors in Decentralized Clinical Trials (DCTs)

By Vistatec Posted on

Life Sciences – In Focus: Leveraging Data and Trends for 2024 – Key Learnings

In the first installment of Vistatec’s Life Sciences – In Focus series, Amanda Murphy, Senior Director of Data Intelligence and Solutions at GlobalData, presented the biopharmaceutical industry’s outlook for 2024. The event yielded valuable insights into the trends and themes predicted for the upcoming year, focusing on the clinical trials landscape, including decentralized clinical trials and diversity. Read the key learnings here. … Continue readingLife Sciences – In Focus: Leveraging Data and Trends for 2024 – Key Learnings

By Vistatec Posted on

Diversity in Clinical Trials: The Role of Language Services

Participant diversity is critical to achieving equitable representation in the clinical trial landscape. Sponsors must proactively plan outreach, enrollment, and retention strategies for diverse communities.
Such strategies should incorporate professional translation, language access, and culturally sensitive localization. Discover the importance of diversity in clinical trials and how LSPs can help.

… Continue readingDiversity in Clinical Trials: The Role of Language Services

By Emily Carroll Posted on

Decoding the Intricacies of Life Sciences Localization – VistaTalks Ep 130

In the intricate world of life sciences, the importance of localization extends far beyond mere translation. It’s a critical component that ensures patient safety, regulatory compliance, and the successful global deployment of medical products and services. María Mateos, an expert in localization and life sciences, recently shed light on the nuances of this field and how companies like Vistatec are leading the charge in providing specialized services that meet the industry’s stringent demands.
… Continue readingDecoding the Intricacies of Life Sciences Localization – VistaTalks Ep 130

By Emily Carroll Posted on

Medtech Innovation and Global Success – Emer Sherry – VistaTalks Ep 128

In this episode, Host Simon Hodgkins is joined by Emer Sherry, Senior Executive, Public Policy and Regulatory Affairs at Irish Medtech Association, Ibec. The Irish Medtech Association is the business association within Ibec representing the medical technology sector. The Irish Medtech Association has more than 250 members located throughout the island of Ireland. The group’s broad focus is to promote and support an environment that encourages the sustainable development and profitable growth of FDI multinational and SME member companies. … Continue readingMedtech Innovation and Global Success – Emer Sherry – VistaTalks Ep 128

By Emily Carroll Posted on

Navigating Medical Device Regulation with Boston Scientific’s Olga van Grol-Lawlor – VistaTalks Ep 127

In this episode, Host Simon Hodgkins is joined by Olga van Grol-Lawlor, Senior Global Regulatory Intelligence and Advocacy Manager at Boston Scientific. The medical device industry stands at the intersection of healthcare and technology, continuously pushing the boundaries of what’s possible. However, with innovation comes the need for regulation, a topic that often finds itself at the center of many industry discussions. … Continue readingNavigating Medical Device Regulation with Boston Scientific’s Olga van Grol-Lawlor – VistaTalks Ep 127

IVDR
By Meredith Hutchinson Posted on

In Vitro Diagnostic Regulation (IVDR)

In vitro diagnoses span a wide range of equipment and tests ranging from simple self-tests to detect pregnancy to complex laboratory diagnostics such as polymerase chain reaction (PCR) testing to diagnose genetic disorders and cancer. Considering the growing importance of in vitro diagnoses, the in vitro diagnostic regulation, or IVDR, was introduced to ensure high quality, outstanding results, and impeccable safety for the sake of all patients and doctors. … Continue readingIn Vitro Diagnostic Regulation (IVDR)

SaMD
By Meredith Hutchinson Posted on

SaMD Regulations and Global Healthcare Innovation

In this article, we want to examine what SaMD is and explore some key differences between SaMD regulations in the EU and US. We’ll also investigate how using artificial intelligence, and machine learning is set to shape the SaMD industry and the critical role SaMD regulations play in establishing trust and reliability in such continuous learning models. … Continue readingSaMD Regulations and Global Healthcare Innovation

By Jordan Knights Posted on

Is Machine Translation Ready for Life Sciences?

Machine translation is on the rise. As more companies adopt machine translation, there is growing evidence that translating first with a machine and adjusting with human revision is faster and more cost-effective than human-only translation in many domains while still capable of achieving human translation quality where this is the objective. … Continue readingIs Machine Translation Ready for Life Sciences?

By Jordan Knights Posted on

Meet our Director of Life Sciences: Kara Bolt

Kara Bolt is a multilingual (German, Spanish, and English) expert in localization and translation at Vistatec. She currently lives in Colorado, United States, where she enjoys the view of surrounding mountains from her home and how dog-friendly the areas are in her neighbourhood. … Continue readingMeet our Director of Life Sciences: Kara Bolt

Think Global Awards 2018 Open for Entries
By Vistatec Posted on

The Think Global Awards 2018 – Open for Entries

The Think Global Awards 2018 – Open for Entries Simon Hodgkins, founder of the Think Global Forum, shares the news of the launch of the Think Global Awards 2018 after … Continue readingThe Think Global Awards 2018 – Open for Entries